These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31468992)

  • 1. A promising cancer diagnosis and treatment strategy: targeted cancer therapy and imaging based on antibody fragment.
    Zhao X; Ning Q; Mo Z; Tang S
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3621-3630. PubMed ID: 31468992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody Fragments as Potential Biopharmaceuticals for Cancer Therapy: Success and Limitations.
    Kholodenko RV; Kalinovsky DV; Doronin II; Ponomarev ED; Kholodenko IV
    Curr Med Chem; 2019; 26(3):396-426. PubMed ID: 28820071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single domain antibodies: a new concept for epidermal growth factor receptor and EGFRvIII targeting.
    Omidfar K; Shirvani Z
    DNA Cell Biol; 2012 Jun; 31(6):1015-26. PubMed ID: 22277093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant antibody fragments and immunotoxin fusions for cancer therapy.
    Brinkmann U
    In Vivo; 2000; 14(1):21-7. PubMed ID: 10757057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments.
    Yazaki PJ; Wu AM; Tsai SW; Williams LE; Ikler DN; Wong JY; Shively JE; Raubitschek AA
    Bioconjug Chem; 2001; 12(2):220-8. PubMed ID: 11312683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-Targeted Molecular Imaging of Cancer.
    Ehlerding EB; Sun L; Lan X; Zeng D; Cai W
    J Nucl Med; 2018 Mar; 59(3):390-395. PubMed ID: 29301927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo imaging with antibodies and engineered fragments.
    Freise AC; Wu AM
    Mol Immunol; 2015 Oct; 67(2 Pt A):142-52. PubMed ID: 25934435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of high avidity antibody fragments (scFv multimers) for cancer imaging.
    Power BE; Hudson PJ
    J Immunol Methods; 2000 Aug; 242(1-2):193-204. PubMed ID: 10986400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor targeting using anti-her2 immunoliposomes.
    Park JW; Kirpotin DB; Hong K; Shalaby R; Shao Y; Nielsen UB; Marks JD; Papahadjopoulos D; Benz CC
    J Control Release; 2001 Jul; 74(1-3):95-113. PubMed ID: 11489487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoimmunotherapy targeting prostate-specific membrane antigen: are antibody fragments as effective as antibodies?
    Watanabe R; Hanaoka H; Sato K; Nagaya T; Harada T; Mitsunaga M; Kim I; Paik CH; Wu AM; Choyke PL; Kobayashi H
    J Nucl Med; 2015 Jan; 56(1):140-4. PubMed ID: 25500827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies in single-chain format against tumour-associated antigens: present and future applications.
    Accardi L; Di Bonito P
    Curr Med Chem; 2010; 17(17):1730-55. PubMed ID: 20345346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies.
    Lane DM; Eagle KF; Begent RH; Hope-Stone LD; Green AJ; Casey JL; Keep PA; Kelly AM; Ledermann JA; Glaser MG
    Br J Cancer; 1994 Sep; 70(3):521-5. PubMed ID: 8080740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody engineering for targeted therapy of cancer: recombinant Fv-immunotoxins.
    Niv R; Cohen CJ; Denkberg G; Segal D; Reiter Y
    Curr Pharm Biotechnol; 2001 Mar; 2(1):19-46. PubMed ID: 11482347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and PET imaging properties of two recombinant anti-PSMA antibody fragments in comparison to their parental antibody.
    Wiehr S; Bühler P; Gierschner D; Wolf P; Rolle AM; Kesenheimer C; Pichler BJ; Elsässer-Beile U
    Prostate; 2014 May; 74(7):743-55. PubMed ID: 24610028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.
    Wong JY; Chu DZ; Williams LE; Yamauchi DM; Ikle DN; Kwok CS; Liu A; Wilczynski S; Colcher D; Yazaki PJ; Shively JE; Wu AM; Raubitschek AA
    Clin Cancer Res; 2004 Aug; 10(15):5014-21. PubMed ID: 15297402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody evolution from the centre to the periphery: applied to a human antibody fragment recognising the tumour-associated antigen mucin-1.
    Jirholt P; Borrebaeck CA; Ohlin M
    J Mol Biol; 2002 Apr; 318(2):407-16. PubMed ID: 12051847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-chain antibodies in pancreatic cancer.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Batra SK
    Ann N Y Acad Sci; 1999 Jun; 880():263-80. PubMed ID: 10415872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted drug delivery using immunoconjugates: principles and applications.
    Pasquetto MV; Vecchia L; Covini D; Digilio R; Scotti C
    J Immunother; 2011; 34(9):611-28. PubMed ID: 21989410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician.
    Lheureux S; Denoyelle C; Ohashi PS; De Bono JS; Mottaghy FM
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(Suppl 1):41-54. PubMed ID: 28396911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques.
    Poduslo JF; Ramakrishnan M; Holasek SS; Ramirez-Alvarado M; Kandimalla KK; Gilles EJ; Curran GL; Wengenack TM
    J Neurochem; 2007 Jul; 102(2):420-33. PubMed ID: 17596213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.